Kidney Biopsy in a Patient with Cardiorenal Metabolic Syndrome—How to Interpret Histopathology
Abstract
:1. Background
2. The Case
3. Discussion
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Whaley-Connell, A.; Sowers, J.R. Basic science: Pathophysiology: The cardiorenal metabolic syndrome. J. Am. Soc. Hypertens 2014, 8, 604–606. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rangaswami, J.; Tuttle, K.; Vaduganathan, M. Cardio-Renal-Metabolic Care Models. Toward Achieving Effective Interdisciplinary Care. Circ. Cardiovasc. Qual. Outcomes 2020, 13, e007264. [Google Scholar] [CrossRef] [PubMed]
- Kadowaki, T.; Maegawa, H.; Watada, H.; Yabe, D.; Node, K.; Murohara, T.; Wada, J. Interconnection between cardiovascular, renal and metabolic disorders: A narrative review with a focus on Japan. Diabetes Obes. Metab. 2022, 24, 2283–2296. [Google Scholar] [CrossRef] [PubMed]
- Mattina, A.; Argano, C.; Brunori, G.; Lupo, U.; Raspanti, M.; Monaco, M.L.; Bocchio, R.M.; Natoli, G.; Giusti, M.A.; Corrao, S. Clinical complexity and diabetes: A multidimensional approach for the management of cardiorenal metabolic syndrome. Nutr. Metab. Cardiovasc. Dis. 2022, 32, 2730–2738. [Google Scholar] [CrossRef] [PubMed]
- Handelsman, Y.; Anderson, J.E.; Bakris, G.L.; Ballantyne, C.M.; Beckman, J.A.; Bhatt, D.L.; Bloomgarden, Z.T.; Bozkurt, B.; Budoff, M.J.; Butler, J.; et al. DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases. J Diabetes Complicat. 2022, 36, 108101. [Google Scholar] [CrossRef] [PubMed]
- Alexander, M.P.; Patel, T.V.; Farag, Y.M.; Florez, A.; Rennke, H.G.; Singh, A.K. Kidney pathological changes in metabolic syndrome: A cross-sectional study. Am. J. Kidney Dis. 2009, 53, 751–759. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Joyce, T.; Chirino, Y.I.; Natalia, M.T.; Jose, P.C. Renal damage in the metabolic syndrome (MetSx): Disorders implicated. Eur. J. Pharmacol. 2018, 5, 554–568. [Google Scholar] [CrossRef] [PubMed]
- Lin, L.; Tan, W.; Pan, X.; Tian, E.; Wu, Z.; Yang, J. Metabolic Syndrome-Related Kidney Injury: A Review and Update. Front. Endocrinol. 2022, 13, 904001. [Google Scholar] [CrossRef] [PubMed]
- Gonçalves, L.B.; Miot, H.A.; Domingues, M.A.C.; Oliveira, C.C. Autopsy Patients with Obesity or Metabolic Syndrome as Basic Cause of Death: Are There Pathological Differences Between These Groups? Clin. Med. Insights Pathol. 2018, 11, 1179555718791575. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wei, L.; Li, Y.; Yu, Y.; Xu, M.; Chen, H.; Li, L.; Peng, T.; Zhao, K.; Zhuang, Y. Obesity-Related Glomerulopathy: From Mechanism to Therapeutic Target. Diabetes Metab. Syndr. Obes. 2021, 28, 4371–4380. [Google Scholar] [CrossRef] [PubMed]
- Yang, S.; Cao, C.; Deng, T.; Zhou, Z. Obesity-Related Glomerulopathy: A Latent Change in Obesity Requiring More Attention. Kidney Blood Press Res. 2020, 45, 510–522. [Google Scholar] [CrossRef] [PubMed]
- De Vries, A.P.; Ruggenenti, P.; Ruan, X.Z.; Praga, M.; Cruzado, J.M.; Bajema, I.M.; DD'Agati, V.; Lamb, H.J.; Barlovic, D.P.; Hojs, R.; et al. ERA-EDTA Working Group Diabesity. Fatty kidney: Emerging role of ectopic lipid in obesity-related renal disease. Lancet Diabetes Endocrinol. 2014, 2, 417–426. [Google Scholar] [CrossRef] [PubMed]
- Allford, S.L.; Hunt, B.J.; Rose, P.; Machin, S.J. Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br. J. Haematol. 2003, 120, 556–573. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Scully, M.; Hunt, B.J.; Benjamin, S.; Liesner, R.; Rose, P.; Peyvandi, F.; Cheung, B.; Machin, S.J.; British Committee for Standards in Haematology. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br. J. Haematol. 2012, 158, 323–335. [Google Scholar] [CrossRef] [PubMed]
- Pickering, M.C.; D’agati, V.D.; Nester, C.M.; Smith, R.J.; Haas, M.; Appel, G.B.; Alpers, C.E.; Bajema, I.M.; Bedrosian, C.; Braun, M.; et al. C3 glomerulopathy: Consensus report. Kidney Int. 2013, 84, 1079–1089. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nester, C.M.; Smith, R.J. Treatment options for C3 glomerulopathy. Curr. Opin. Nephrol. Hypertens 2013, 22, 231–237. [Google Scholar] [CrossRef] [PubMed]
- Schena, F.P.; Esposito, P.; Rossini, M. A Narrative Review on C3 Glomerulopathy: A Rare Renal Disease. Int. J. Mol. Sci. 2020, 21, 525. [Google Scholar] [CrossRef] [PubMed] [Green Version]
10.2014 | 11.2019 | 01.2020 | 11.2021 | 02.2022 | |
---|---|---|---|---|---|
SCr µmol/L (53–115) | 203 | 198 | 225 | 255 | 254 |
eGFR CKD-EPI mL/min/1.73 m2 | 35 | 35 | 30 | 25 | 25 |
UA µmol/L (155–428) | 527 | 604 | 621 | 690 | 661 |
TCh mmol/L (1.3–5.3) | 6.03 | 6.33 | 6.01 | 7.90 | 7.24 |
HDL mmol/L (1.0–1.55) | 0.76 | 0.94 | 1.09 | ||
LDL mmol/L (1.9–3.3) | 3.74 | 3.93 | 5.09 | ||
TG mmol/L (0.6–2.3) | 3.46 | 4.97 | 6.47 | ||
AC (2.28–3.02) | 7.0 | 5.4 | 6.3 | ||
FG mmol/L (3.5–5.56) | 5.3 | 8.2 | 6.0 | 6.8 | 7.1 |
PU g/24 h (0.0–0.15) | 0.8 | 2.7 | 4.0 | 0.9 | 0.4 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Zakharova, E.; Vorobyeva, O. Kidney Biopsy in a Patient with Cardiorenal Metabolic Syndrome—How to Interpret Histopathology. Kidney Dial. 2023, 3, 171-177. https://doi.org/10.3390/kidneydial3020015
Zakharova E, Vorobyeva O. Kidney Biopsy in a Patient with Cardiorenal Metabolic Syndrome—How to Interpret Histopathology. Kidney and Dialysis. 2023; 3(2):171-177. https://doi.org/10.3390/kidneydial3020015
Chicago/Turabian StyleZakharova, Elena, and Olga Vorobyeva. 2023. "Kidney Biopsy in a Patient with Cardiorenal Metabolic Syndrome—How to Interpret Histopathology" Kidney and Dialysis 3, no. 2: 171-177. https://doi.org/10.3390/kidneydial3020015
APA StyleZakharova, E., & Vorobyeva, O. (2023). Kidney Biopsy in a Patient with Cardiorenal Metabolic Syndrome—How to Interpret Histopathology. Kidney and Dialysis, 3(2), 171-177. https://doi.org/10.3390/kidneydial3020015